Contribute Try STAT+ Today

Scientists have produced Covid-19 vaccines in record time. But the digital connectivity needed to closely track doses, side effects, and continuing infections is still lagging behind — even though the technology is now widely available.

This paradox of the pandemic was on display Tuesday during a meeting hosted by the Department of Health and Human Services. An official with the U.S. Digital Service said site visits to public health agencies around the country in recent months revealed a heavy reliance on paper documents and fax machines to collect and share data on Covid-19 tests.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.